Food and Drug Administration (FDA) approved semaglutide (Wegovy) for chronic weight management in adults with obesity or overweight individuals who have at least one weight-related health condition, such as hypertension, type 2 diabetes, or high cholesterol
How do I get the most out of both
In diabetic patients, higher glucose levels and greater glycemic variability promote a pro-inflammatory state, which leads to defects in microvasculature characteristic of DR [78]
Moreover, Phase 2 findings showed that weekly amylin agonism produced substantial mean weight reduction as monotherapy, reaching 20.1% at 48 weeks in the highest fixed-dose arm under the efficacy estimand
Timing and Portion Control Strategies to Reduce Nausea Eating smaller, more frequent meals is one of the most effective ways to prevent semaglutide-related nausea